The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cell-free circulating tumor DNA (cfDNA) to identify germline (GL) and somatic BRCA alterations (alts) in men with advanced prostate cancer (ProsCA).
 
Victoria M. Raymond
Employment - Guardant Health; Trovagene
Stock and Other Ownership Interests - Guardant Health; Trovagene
 
Tanisha M. Mojica
No Relationships to Disclose
 
Elizabeth V. Harris
No Relationships to Disclose
 
Richard B. Lanman
Employment - Guardant Health; Veracyte
Leadership - Biolase; Guardant Health
Stock and Other Ownership Interests - Biolase; Guardant Health
Research Funding - Guardant Health
 
Celestia S. Higano
Employment - CTI (I)
Leadership - CTI (I)
Stock and Other Ownership Interests - CTI (I)
Honoraria - Genentech
Consulting or Advisory Role - Asana Biosciences; Astellas Pharma; Bayer; Blue Earth Diagnostics; Clovis Oncology; Dendreon; Endocyte; Ferring; Myriad Genetics; Orion; Tolmar
Research Funding - Aragon Pharmaceuticals (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Dendreon (Inst); Emergent BioSolutions (Inst); Genentech (Inst); Medivation (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Asana Biosciences; Astellas Pharma; Bayer; Blue Earth Diagnostics; Clovis Oncology; Dendreon; Endocyte; Ferring; Genentech; Menarini; Myriad Genetics; Orion; Pfizer